BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 30988224)

  • 1. [Tuberous Sclerosis Complex].
    Kaneda M
    Brain Nerve; 2019 Apr; 71(4):374-379. PubMed ID: 30988224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal disease in tuberous sclerosis complex: pathogenesis and therapy.
    Lam HC; Siroky BJ; Henske EP
    Nat Rev Nephrol; 2018 Nov; 14(11):704-716. PubMed ID: 30232410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Finding a cure for tuberous sclerosis complex: From genetics through to targeted drug therapies.
    McEneaney LJ; Tee AR
    Adv Genet; 2019; 103():91-118. PubMed ID: 30904097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of 6-phosphofructo-2-kinase (PFKFB3) by hyperactivated mammalian target of rapamycin complex 1 is critical for tumor growth in tuberous sclerosis complex.
    Wang Y; Tang S; Wu Y; Wan X; Zhou M; Li H; Zha X
    IUBMB Life; 2020 May; 72(5):965-977. PubMed ID: 31958214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberous sclerosis complex: Recent advances in manifestations and therapy.
    Wataya-Kaneda M; Uemura M; Fujita K; Hirata H; Osuga K; Kagitani-Shimono K; Nonomura N;
    Int J Urol; 2017 Sep; 24(9):681-691. PubMed ID: 28667702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberous sclerosis in a patient from Nigeria.
    Ekure EN; Addissie YA; Sokunbi OJ; Kruszka P; Muenke M; Adeyemo AA
    Am J Med Genet A; 2019 Aug; 179(8):1423-1425. PubMed ID: 31140686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tuberous sclerosis complex: A review].
    Pfirmann P; Combe C; Rigothier C
    Rev Med Interne; 2021 Oct; 42(10):714-721. PubMed ID: 33836894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-level mosaicism in tuberous sclerosis complex in four unrelated patients: Comparison of clinical characteristics and diagnostic pathways.
    Manzanilla-Romero HH; Weis D; Schnaiter S; Rudnik-Schöneborn S
    Am J Med Genet A; 2021 Dec; 185(12):3851-3858. PubMed ID: 34328706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mourning Dr. Alfred G. Knudson: the two-hit hypothesis, tumor suppressor genes, and the tuberous sclerosis complex.
    Hino O; Kobayashi T
    Cancer Sci; 2017 Jan; 108(1):5-11. PubMed ID: 27862655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberous sclerosis: immunohistochemistry expression of tuberin and hamartin in a 31-week gestational fetus.
    Vinaitheerthan M; Wei J; Mizuguchi M; Greco A; Barness EG
    Fetal Pediatr Pathol; 2004; 23(4):241-9. PubMed ID: 16095035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberous Sclerosis Complex in Chinese patients: Phenotypic analysis and mutational screening of TSC1/TSC2 genes.
    Lin S; Zeng JB; Zhao GX; Yang ZZ; Huang HP; Lin MT; Wu ZY; Wang N; Chen WJ; Fang L
    Seizure; 2019 Oct; 71():322-327. PubMed ID: 31525612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of the Tuberous Sclerosis Complex 2 (TSC2) N Terminus Provides Insight into Complex Assembly and Tuberous Sclerosis Pathogenesis.
    Zech R; Kiontke S; Mueller U; Oeckinghaus A; Kümmel D
    J Biol Chem; 2016 Sep; 291(38):20008-20. PubMed ID: 27493206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The specificity and role of microglia in epileptogenesis in mouse models of tuberous sclerosis complex.
    Zhang B; Zou J; Han L; Beeler B; Friedman JL; Griffin E; Piao YS; Rensing NR; Wong M
    Epilepsia; 2018 Sep; 59(9):1796-1806. PubMed ID: 30079598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of expression of tuberin and hamartin in tuberous sclerosis complex-associated but not in sporadic angiofibromas.
    Fackler I; DeClue JE; Rust H; Vu PA; Kutzner H; Rütten A; Kaddu S; Sander CA; Volkenandt M; Johnson MW; Vinters HV; Wienecke R
    J Cutan Pathol; 2003 Mar; 30(3):174-7. PubMed ID: 12641776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathology of hereditary renal cell carcinoma syndromes: Tuberous sclerosis complex (TSC).
    Machacek ME; Wu CL; Cornejo KM
    Semin Diagn Pathol; 2024 Jan; 41(1):8-19. PubMed ID: 37993384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberous sclerosis complex: genetics to pathogenesis.
    Narayanan V
    Pediatr Neurol; 2003 Nov; 29(5):404-9. PubMed ID: 14684235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of the tuberous sclerosis complex protein tuberin causes Purkinje cell degeneration.
    Reith RM; Way S; McKenna J; Haines K; Gambello MJ
    Neurobiol Dis; 2011 Jul; 43(1):113-22. PubMed ID: 21419848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental expression of the tuberous sclerosis proteins tuberin and hamartin.
    Murthy V; Stemmer-Rachamimov AO; Haddad LA; Roy JE; Cutone AN; Beauchamp RL; Smith N; Louis DN; Ramesh V
    Acta Neuropathol; 2001 Mar; 101(3):202-10. PubMed ID: 11307618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for separable functions of tuberous sclerosis gene products in mammalian cell cycle regulation.
    Miloloza A; Kubista M; Rosner M; Hengstschläger M
    J Neuropathol Exp Neurol; 2002 Feb; 61(2):154-63. PubMed ID: 11853018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal glycogen storage in tuberous sclerosis complex caused by impairment of mTORC1-dependent and -independent signaling pathways.
    Pal R; Xiong Y; Sardiello M
    Proc Natl Acad Sci U S A; 2019 Feb; 116(8):2977-2986. PubMed ID: 30728291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.